Compartir
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases With Co-Morbidity Factors Part b (Volume 172) (International Review of Neurobiology, Volume 172) (en Inglés)
Sharma Hari Shanker,Wiklund Lars,Sharma Aruna (Autor)
·
Academic Press
· Nuevo
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases With Co-Morbidity Factors Part b (Volume 172) (International Review of Neurobiology, Volume 172) (en Inglés) - Sharma Hari Shanker,Wiklund Lars,Sharma Aruna
$ 202.61
$ 311.71
Ahorras: $ 109.10
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Martes 11 de Junio y el
Viernes 21 de Junio.
Lo recibirás en cualquier lugar de Ecuador entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases With Co-Morbidity Factors Part b (Volume 172) (International Review of Neurobiology, Volume 172) (en Inglés)"
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Part B, Volume 172 in the International Review of Neurobiology series, includes chapters on Spinal cord injury induced exacerbation of Alzheimer's disease pathophysiology in the cord is reduced by topical application of nanowired cerebrolysin and antibodies to tumor necrosis factor alpha, Nanodelivery of histamine H3 receptor inverse agonist BF-2549 with clobenpropit a H3 receptor antagonist and H4 receptor agonist induced neuroprotection in spinal cord injury is potentiated by antioxidant compound H-290/51, and Neuromodulation and quality of life for patient with spasticity after spinal cord injury, and more. Other sections cover Efficacy of invasive and non-invasive methods for the treatment of Parkinson s disease: nanodelivery and enriched environment, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Nicotine Neurotoxicity Exacerbation following Engineered Ag and Cu (50-60 nm) nanoparticles intoxication, and Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron.
